Introduction
Chitosan is a β -1, 4-D-glucosamine polymer derived from the alkaline N-deacetylation of chitin. The latter is a structural component of fungi, insects and crustaceans that is insoluble in most solvents, with the exception of organic acids, e.g., acetic acid [1, 2] . Chitosan is a nontoxic, biocompatible and biodegradable product that displays diverse biological and therapeutic properties, including antimicrobial trace metals and inhibiting mRNA synthesis [1, 17] . Potential synergistic effects between LMWC and conventional drugs, including fl uconazole, have yet to be explored. This is the fi rst time that the antifungal activity of LMWC against 105 clinical isolates of Candida spp. is evaluated. Previous studies have only measured its activity against a few strains of Candida spp. [3] or environmental fungi [1, 5, 17] . LMWC exhibited antifungal activity inhibiting over 90% of the clinical strains at pH 4.0. There was no evidence of synergism between LMWC and fl uconazole at pH 7.0, since higher pH levels affect the in vitro activity of the drug. 
Materials and methods

Strains
Antifungal fl uconazole susceptibility testing of clinical strains
In vitro antifungal susceptibility tests of the isolates (AST) to fl uconazole was performed with a broth microdilution method, in accord with the standards of the European Committee on Antifungal Susceptibility Testing (EUCAST-ASFT) [22] , employing C. krusei ATCC 6258 and C. parapsilosis ATCC 22019 as controls. Resistance to fl uconazole (Pfi zer) was assessed according EUCAST-AFST standard [22 -24] .
Evaluation of LMWC antifungal activity
Low molecular weight samples of chitosan (Mw ϭ 70 KDa, Ͼ 75% deacetylation) from Fluka were washed with acetone and methanol and dried to a constant weight [25] . Optimal test conditions were established prior to determining the minimum inhibitory concentrations (MICs) of isolates by the broth microdilution method. Solubility assays of LMWC were performed with RPMI 1640 (Gibco) containing 2% glucose at pH 7.0 and 4.0, plus acetic acid at varying concentrations (0.01%, 0.1% and 1%). To evaluate the minimum acetic acid concentration that had no effect on the viability of the yeasts, growth curves were determined with the control strain C. albicans ATCC 64550 in RPMI 1640 plus 2% glucose at pH 7.0, 4.5 and 4.0, and in varying concentrations of acetic acid (as above). The highest amount of LMWC dissolved by 0.1% acetic acid was 7,400 mg/l. To estimate the antifungal activity of LMWC, growth curves of C. albicans ATCC 64550 were generated in the presence of LMWC, i.e., 5, 000, 1, 000 and 100 mg/l in RPMI 1640 plus 2% glucose and in 0.1% acetic acid. Yeast viability was evaluated by colony counts.
To determine the effect of pH on the antifungal activity of LMWC, we tested control and 30 clinical strains. The MICs of chitosan were measured according to EUCAST methodology [22] , with some modifi cations, i.e., the acetic acid used to dissolve LMWC reached a fi nal concentration of 0.1% in the wells of the microplates. MIC measurements were performed using a spectrophotometer at pH 7.0 and 4.0, and LMWC concentrations in the range of 0.5 -128 mg/l.
Once the experimental conditions were optimized, MICs of LMWC against all clinical strains and controls were measured using a concentration range of 4.8 -2500 mg/l at pH 4.0.
Analysis of synergism between LMWC and fl uconazole
Analysis of potential synergy between LMWC and fl uconazole was carried out by the chequerboard method [26] at pH 7.0 due to the fact that the antifungal activity of fl uconazole is negatively affected at acidic pH [27] . A previous study in our laboratory demonstrated antifungal activity of chitosan against 2 ATCC strains ( C. parapsilosis ATCC 22019 and C. krusei ATCC 62258) at pH 7.0 [28] . The fractional inhibitory concentrations of chitosan and fl uconazole were calculated for 9 clinical isolates of Candida spp. and for control strains according to the following formula: (A)/(MICA) ϩ (B)/(MICB) ϭ FICA ϩ FICB ϭ Fractional inhibitory concentration (FIC) index. In this formula (A) is the concentration of drug A in a tube that is the lowest inhibitory concentration in its row, (MICA) is the MIC to drug A alone, and FICA the fractional inhibitory concentration of drug A. The formula components (B), (MICB) and FICB are defi ned in the same fashion but for drug B [26] . Fractional inhibitory concentration index (FICI) values were interpreted as follows; a FICI value of less than 0.5 was considered synergistic, 0.5 to 4 was indifferent, and greater than 4 were considered antagonistic [26] . We also generated death curves using as the control strain C. tropicalis Rex MY1012, which was inhibited by low concentrations of LMWC, for which the MIC of fuconazole was 32 mg/l. 
Results and discussion
We evaluated different solvents for LMWC and found that 4,900 -7,400 mg/l of chitosan was soluble in 0.01 -0.1% acetic acid, respectively, whereas chitosan was insoluble in DMSO. The minimum concentration of acetic acid that had no effect on the viability of the yeast strains was 0.1% (Fig. 1) . Thus, we used 0.1% acetic acid as the solvent in our studies. It is important to note that acetic acid inhibits the growth of C. albicans at concentrations of 1% and higher. In previous investigations in which the antimicrobial activity of different molecular weight chitosan compounds or its derivatives were evaluated, acetic acid was used as a solvent but its effect on cell viability was not studied [1, 5] . Although dimethyl sulfoxide is commonly used to dissolve drugs that are water insoluble, we found that LMWC was insoluble in this solvent (data not shown). Dimethyl sulfoxide has been used in prior studies to dissolve hydrophobic chitosan derivates [29] .
We also evaluated the effect of pH on the viability of fungal cells. The growth of C. albicans was not affected at pH 4.0, but was at neutral pH ( Fig. 1) . At pH 4.0, the antifungal activity of LMWC against C. albicans ATCC 64550 was evident at concentrations of 1,000 and 5,000 mg/l of LMWC (Fig. 2) .
Using a lower concentration range of LMWC (between 0.5 and 128 mg/l), its antifungal activity against several strains was greater at acidic pH, with MICs between 1-and 4-fold lower at pH 4.0 (Table 1) . Some reports have suggested that the polycationic character of chitosan is the most important mechanism of antifungal activity, as the cationic groups would interact with anionic components of the cell wall of the fungus, and destabilize the membrane [1, 17] . We observed that the antifungal activity of LMWC increased at acidic pH which might be due to the protonation of the amino group of glucosamine units of chitosan at pH 4.0 as the pKa of LMWC is 6.3 [1, 30] . At pH 7.0, we observed a lower antifungal activity, which was restored when the measurements were conducted at acidic pH (4.0) ( Table 1) . Interestingly, vulvovaginal candidiasis is a frequent infection of the female genital tract. The latter is maintained at pH 4.0 or 4.5 raising the possibility of the use of LMWC as a therapeutic treatment for this type of infection.
Most of the clinical strains were inhibited within the range of 4.8 and 2,500 mg/l LMWC at pH 4.0 (Fig. 3) . Antifungal activity of chitosan and its derivatives [3, 5, 16, 17, 28, 30] has previously been demonstrated against members of the genus Candida , primarily those species associated with human infections, such as C. albicans , C. krusei and C. glabrata [3] . In this investigation we evaluated a number of important clinical isolates associated with candidiasis ( n ϭ 105) and found that LMWC had marked antifungal activity. Nearly 90% of the strains were inhibited by LMWC, 68.6% of which were inhibited at a concentration of 4.8 mg/l at pH 4.0 (Fig. 3) . When we compared the susceptibility of the strains to LMWC with fl uconazole, eight out of nine strains of C. albicans and C. tropicalis which were resistant to the latter according to EUCAST breakpoints (MIC Ͼ 4 mg/l), were inhibited by LMWC of 9.8 mg/l or less (Table 2) [23] . On the other hand, nine strains (six C. albicans , one C. famata and two C. krusei ) for which the MIC of fl uconazole was 64 mg/l or higher had a LMWC MIC of 9.8 mg/l or less (data not shown). These results suggested that LMWC could be a therapeutic alternative with Candida isolates that show 
some degree of in vitro resistance to antifungal drugs such as fl uconazole. Seven of 12 strains of C. glabrata that presented high MICs of 16 mg/l or greater to fl uconazole were inhibited by LMWC concentrations less than 4.8 mg/l. However fi ve strains of this species required concentrations of 2,500 mg/l of LMWC or greater (data not shown). These results were consistent with a previous study in which strains of C. glabrata exhibited higher resistance to LMWC [3] . In assays of eight control strains and nine clinical isolates of Candida spp., LMWC was not synergistic with fl uconazole at pH 7.0, although some strains had FICI values that were closer to synergy at 0.5 (data not shown).
It is important to emphasize that antagonism between LMWC and fl uconazole was not observed, which lends support to the idea that LMWC could be used for the delivery of conventional antifungal drugs [31 -33] . Combination of LMWC and fl uconazole at acidic pH was not performed because fl uconazole is inactive in vitro at a pH near to 4.0 [27] , although an in vivo synergism cannot be discounted. A previous study evaluated the effect of fl uconazole on Candida albicans under in vitro conditions resembling the vaginal microenvironment. In this study, fl uconazole showed a fungicidal synergistic effect at pH 4.2 by its combination with acetic acid [27] .
Given that conventional antifungal therapies are currently insuffi cient to control some mycoses, these results open new therapeutic options for antifungal treatment. The low toxicity of chitosan in humans [2, 17] also supports LMWC as a good candidate for new applications. LMWC represents an innovative agent for topical use in the treatment of superfi cial mycoses, such as vulvovaginal candidiasis, because it is not absorbed by the intestinal tract [2, 34, 35] . Finally, since LMWC is soluble at pH 4.0, it would be effective in the treatment of candidiasis, which commonly occurs in an environment of pH 4.0 -4.5, even in the case of C. glabrata . 
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